肿瘤浸润性淋巴细胞(tumor infiltrating lymphocytes,til)是新一代抗肿瘤过继免疫效应细胞［9］，其中cd3+t细胞约占70～80%，而anti-cd3-mca...
基于2102个网页-相关网页
③肿瘤浸润性淋巴细胞（tumor-infiltration lymphocytes，TIL）：是浸润于实体瘤内和周围淋巴结中，往往已被肿瘤抗原致敏而具有特异性抗肿瘤作用的一类细胞。
基于34个网页-相关网页
） 这种疗法初见成效的曙光开始于对肿瘤浸润性淋巴细胞（Tumor-infiltrating Lymphocytes，TIL）的研究，TIL也是最早的ACT回输细胞。一开始的做法就是将TIL从肿瘤细胞中分离出来，在体外用IL-2扩增，再系统回输给淋巴细胞...
基于12个网页-相关网页
和肿瘤浸润性淋巴细胞 tumor-infiltrating lympbocytes
到肿瘤浸润性淋巴细胞 tumor infiltrating lymphocytes
③肿瘤浸润性淋巴细胞 tumor-infiltration lymphocyte
的肿瘤浸润性淋巴细胞 tumor infiltrating lymphocytes
癌肿瘤浸润性淋巴细胞 tumor infiltrating lymphocytes
及肿瘤浸润性淋巴细胞 tumor-infiltrating lympbocytes
目的研究肺癌原代细胞和细胞系a549对肿瘤浸润性淋巴细胞的抑制作用及其临床意义。
Objective To study the inhibition of lung cancer cells of primary culture and A549 cell line on the proliferation of tumor-infiltrating lymphocytes (TIL) in vitro and its clinical implications.
对两例原发性肾癌患者手术切除肿瘤组织中肿瘤浸润性淋巴细胞（TIL）进行了体外分离与培养。
Tumor-infiltrating lymphocytes (TIL) isolated from two renal cell carcinoma were cultured in vitro in the presence of rh IL-2.
目的研究两种不同肿瘤组织中分离的肿瘤浸润性淋巴细胞在冷冻瘤苗刺激下的增殖反应和抗肿瘤作用。
Objective To observe the capacity of proliferation and anticancerous activity of TIL from two different tumor organs stimulated by freezing cancer vaccines.
应用推荐